TY - JOUR AU - Fisher, R. AU - Pusztai, L. AU - Swanton, C. PY - 2013 DA - 2013// TI - Cancer heterogeneity: implications for targeted therapeutics JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2012.581 DO - 10.1038/bjc.2012.581 ID - Fisher2013 ER - TY - JOUR AU - Rupp, T. AU - Zuckerman, D. PY - 2017 DA - 2017// TI - Quality of life, overall survival, and costs of Cancer drugs approved based on surrogate endpoints JO - JAMA Intern Med VL - 177 UR - https://doi.org/10.1001/jamainternmed.2016.7761 DO - 10.1001/jamainternmed.2016.7761 ID - Rupp2017 ER - TY - JOUR AU - Zou, J. AU - Wang, E. PY - 2018 DA - 2018// TI - Cancer biomarker discovery for precision medicine: new progresses JO - Curr Med Chem VL - 26 UR - https://doi.org/10.2174/0929867325666180718164712 DO - 10.2174/0929867325666180718164712 ID - Zou2018 ER - TY - JOUR AU - Goossens, N. AU - Nakagawa, S. AU - Sun, X. AU - Hoshida, Y. PY - 2015 DA - 2015// TI - Cancer biomarker discovery and validation JO - Transl Cancer Res VL - 4 ID - Goossens2015 ER - TY - CHAP AU - Boyd, M. R. ED - Teicher, B. A. PY - 1997 DA - 1997// BT - The NCI in vitro anticancer drug discovery screen. in anticancer drug development guide: preclinical screening, clinical trials, and approval PB - Humana Press CY - Totowa UR - https://doi.org/10.1007/978-1-4615-8152-9_2 DO - 10.1007/978-1-4615-8152-9_2 ID - Boyd1997 ER - TY - JOUR AU - Yang, W. PY - 2013 DA - 2013// TI - Genomics of drug sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells JO - Nucleic Acids Res VL - 41 UR - https://doi.org/10.1093/nar/gks1111 DO - 10.1093/nar/gks1111 ID - Yang2013 ER - TY - JOUR AU - Barretina, J. PY - 2012 DA - 2012// TI - The Cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity JO - Nature VL - 483 UR - https://doi.org/10.1038/nature11003 DO - 10.1038/nature11003 ID - Barretina2012 ER - TY - JOUR AU - Bansal, M. PY - 2014 DA - 2014// TI - A community computational challenge to predict the activity of pairs of compounds JO - Nat Biotechnol VL - 32 UR - https://doi.org/10.1038/nbt.3052 DO - 10.1038/nbt.3052 ID - Bansal2014 ER - TY - JOUR AU - Ferriss, J. S. PY - 2012 DA - 2012// TI - Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0030550 DO - 10.1371/journal.pone.0030550 ID - Ferriss2012 ER - TY - JOUR AU - Shen, K. PY - 2012 DA - 2012// TI - A systematic evaluation of multi-gene predictors for the pathological response of breast cancer patients to chemotherapy JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0049529 DO - 10.1371/journal.pone.0049529 ID - Shen2012 ER - TY - JOUR AU - Lee, J. K. PY - 2010 DA - 2010// TI - Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancer JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-2247 DO - 10.1158/1078-0432.CCR-09-2247 ID - Lee2010 ER - TY - JOUR AU - Kim, Y. PY - 2014 DA - 2014// TI - Retrospective analysis of survival improvement by molecular biomarker-based personalized chemotherapy for recurrent ovarian cancer JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0086532 DO - 10.1371/journal.pone.0086532 ID - Kim2014 ER - TY - JOUR AU - Kim, Y. AU - Dillon, P. M. AU - Park, T. AU - Lee, J. K. PY - 2018 DA - 2018// TI - CONCORD biomarker prediction for novel drug introduction to different cancer types JO - Oncotarget VL - 9 UR - https://doi.org/10.18632/oncotarget.23124 DO - 10.18632/oncotarget.23124 ID - Kim2018 ER - TY - JOUR AU - Byrne, A. T. PY - 2017 DA - 2017// TI - Interrogating open issues in cancer precision medicine with patient-derived xenografts JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2016.140 DO - 10.1038/nrc.2016.140 ID - Byrne2017 ER - TY - JOUR AU - Hollingshead, M. G. PY - 2014 DA - 2014// TI - Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies JO - BMC Genomics VL - 15 UR - https://doi.org/10.1186/1471-2164-15-393 DO - 10.1186/1471-2164-15-393 ID - Hollingshead2014 ER - TY - JOUR AU - Hidalgo, M. PY - 2014 DA - 2014// TI - Patient-derived xenograft models: an emerging platform for translational cancer research JO - Cancer Dis VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-14-0001 DO - 10.1158/2159-8290.CD-14-0001 ID - Hidalgo2014 ER - TY - JOUR AU - Bruna, A. PY - 2016 DA - 2016// TI - A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds JO - Cell VL - 167 UR - https://doi.org/10.1016/j.cell.2016.08.041 DO - 10.1016/j.cell.2016.08.041 ID - Bruna2016 ER - TY - JOUR AU - Miller, L. D. PY - 2005 DA - 2005// TI - An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0506230102 DO - 10.1073/pnas.0506230102 ID - Miller2005 ER - TY - JOUR AU - Tabchy, A. PY - 2010 DA - 2010// TI - Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-1265 DO - 10.1158/1078-0432.CCR-10-1265 ID - Tabchy2010 ER - TY - JOUR AU - Esserman, L. J. PY - 2012 DA - 2012// TI - Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) JO - Breast Cancer Res Treat VL - 132 UR - https://doi.org/10.1007/s10549-011-1895-2 DO - 10.1007/s10549-011-1895-2 ID - Esserman2012 ER - TY - JOUR AU - Horak, C. E. PY - 2013 DA - 2013// TI - Biomarker analysis of neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage breast cancer JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-1359 DO - 10.1158/1078-0432.CCR-12-1359 ID - Horak2013 ER - TY - JOUR AU - Hatzis, C. PY - 2011 DA - 2011// TI - A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer JO - JAMA VL - 305 UR - https://doi.org/10.1001/jama.2011.593 DO - 10.1001/jama.2011.593 ID - Hatzis2011 ER - TY - JOUR AU - Miyake, T. PY - 2012 DA - 2012// TI - GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer JO - Cancer Sci VL - 103 UR - https://doi.org/10.1111/j.1349-7006.2012.02231.x DO - 10.1111/j.1349-7006.2012.02231.x ID - Miyake2012 ER - TY - JOUR AU - Popovici, V. PY - 2010 DA - 2010// TI - Effect of training-sample size and classification difficulty on the accuracy of genomic predictors JO - Breast Cancer Res VL - 12 UR - https://doi.org/10.1186/bcr2468 DO - 10.1186/bcr2468 ID - Popovici2010 ER - TY - JOUR AU - Slamon, D. PY - 2011 DA - 2011// TI - Adjuvant trastuzumab in HER2-positive breast cancer JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa0910383 DO - 10.1056/NEJMoa0910383 ID - Slamon2011 ER - TY - JOUR AU - Menard, S. AU - Pupa, S. M. AU - Campiglio, M. AU - Tagliabue, E. PY - 2003 DA - 2003// TI - Biologic and therapeutic role of HER2 in cancer JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206779 DO - 10.1038/sj.onc.1206779 ID - Menard2003 ER - TY - JOUR AU - Perez, E. A. PY - 2015 DA - 2015// TI - Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the north central Cancer treatment group n9831 adjuvant Trastuzumab trial JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.6298 DO - 10.1200/JCO.2014.57.6298 ID - Perez2015 ER - TY - JOUR AU - Adamska, A. AU - Domenichini, A. AU - Falasca, M. PY - 2017 DA - 2017// TI - Pancreatic ductal adenocarcinoma: current and evolving therapies JO - Int J Mol Sci VL - 18 UR - https://doi.org/10.3390/ijms18071338 DO - 10.3390/ijms18071338 ID - Adamska2017 ER - TY - JOUR AU - Badea, L. AU - Herlea, V. AU - Dima, S. O. AU - Dumitrascu, T. AU - Popescu, I. PY - 2008 DA - 2008// TI - Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia JO - Hepatogastroenterology VL - 55 ID - Badea2008 ER - TY - JOUR AU - Chen, D. T. PY - 2015 DA - 2015// TI - Prognostic fifteen-gene signature for early stage pancreatic ductal adenocarcinoma JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0133562 DO - 10.1371/journal.pone.0133562 ID - Chen2015 ER - TY - STD TI - Christof Winter, Glen Kristiansen, Stephan Kersting, Janine Roy, Daniela Aust, Thomas Knösel, Petra Rümmele, Beatrix Jahnke, Vera Hentrich, Felix Rückert, Marco Niedergethmann, Wilko Weichert, Marcus Bahra, Hans J. Schlitt, Utz Settmacher, Helmut Friess, Markus Büchler, Hans-Detlev Saeger, Michael Schroeder, Christian Pilarsky, Robert Grützmann, Donna K. Slonim. Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based. Ranking of Marker Genes. PLoS Computational Biology 8(5):e1002511. ID - ref31 ER - TY - JOUR AU - Collisson, E. A. PY - 2011 DA - 2011// TI - Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy JO - Nat Med VL - 17 UR - https://doi.org/10.1038/nm.2344 DO - 10.1038/nm.2344 ID - Collisson2011 ER - TY - JOUR AU - Zhang, J. J. PY - 2011 DA - 2011// TI - International Cancer genome consortium data portal-a one-stop shop for cancer genomics data JO - Database VL - 2011 ID - Zhang2011 ER - TY - JOUR AU - Watanabe, T. PY - 2011 DA - 2011// TI - Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients JO - Clin Transl Oncol VL - 13 UR - https://doi.org/10.1007/s12094-011-0676-z DO - 10.1007/s12094-011-0676-z ID - Watanabe2011 ER - TY - JOUR AU - Muhale, F. A. AU - Wetmore, B. A. AU - Thomas, R. S. AU - McLeod, H. L. PY - 2011 DA - 2011// TI - Systems pharmacology assessment of the 5-fluorouracil pathway JO - Pharmacogenomics VL - 12 UR - https://doi.org/10.2217/pgs.10.188 DO - 10.2217/pgs.10.188 ID - Muhale2011 ER - TY - JOUR AU - Rio, M. PY - 2007 DA - 2007// TI - Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.07.4187 DO - 10.1200/JCO.2006.07.4187 ID - Rio2007 ER - TY - JOUR AU - Marisa, L. PY - 2013 DA - 2013// TI - Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value JO - PLoS Med VL - 10 UR - https://doi.org/10.1371/journal.pmed.1001453 DO - 10.1371/journal.pmed.1001453 ID - Marisa2013 ER - TY - JOUR AU - Ychou, M. PY - 2009 DA - 2009// TI - A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn680 DO - 10.1093/annonc/mdn680 ID - Ychou2009 ER - TY - JOUR AU - Cutsem, E. PY - 2009 DA - 2009// TI - Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3 JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.6663 DO - 10.1200/JCO.2008.21.6663 ID - Cutsem2009 ER - TY - JOUR AU - Khambata-Ford, S. PY - 2007 DA - 2007// TI - Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.10.5437 DO - 10.1200/JCO.2006.10.5437 ID - Khambata-Ford2007 ER - TY - JOUR AU - Stefano, A. AU - Carlomagno, C. PY - 2014 DA - 2014// TI - Beyond KRAS: predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer JO - World J Gastroenterol VL - 20 UR - https://doi.org/10.3748/wjg.v20.i29.9732 DO - 10.3748/wjg.v20.i29.9732 ID - Stefano2014 ER - TY - JOUR AU - Zappa, C. AU - Mousa, S. A. PY - 2016 DA - 2016// TI - Non-small cell lung cancer: current treatment and future advances JO - Transl Lung Cancer Res VL - 5 UR - https://doi.org/10.21037/tlcr.2016.06.07 DO - 10.21037/tlcr.2016.06.07 ID - Zappa2016 ER - TY - JOUR AU - Tarca, A. L. PY - 2013 DA - 2013// TI - Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER diagnostic signature challenge JO - Bioinformatics VL - 29 UR - https://doi.org/10.1093/bioinformatics/btt492 DO - 10.1093/bioinformatics/btt492 ID - Tarca2013 ER - TY - JOUR AU - Balko, J. M. PY - 2006 DA - 2006// TI - Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors JO - BMC Genomics VL - 7 UR - https://doi.org/10.1186/1471-2164-7-289 DO - 10.1186/1471-2164-7-289 ID - Balko2006 ER - TY - JOUR AU - Baty, F. PY - 2013 DA - 2013// TI - EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0072966 DO - 10.1371/journal.pone.0072966 ID - Baty2013 ER - TY - JOUR AU - Byers, L. A. PY - 2013 DA - 2013// TI - An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-1558 DO - 10.1158/1078-0432.CCR-12-1558 ID - Byers2013 ER - TY - JOUR AU - Chang, D. K. PY - 2015 DA - 2015// TI - Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo JO - Mol Cancer VL - 14 UR - https://doi.org/10.1186/s12943-015-0384-3 DO - 10.1186/s12943-015-0384-3 ID - Chang2015 ER - TY - JOUR AU - Wettenhall, J. M. AU - Smyth, G. K. PY - 2004 DA - 2004// TI - limmaGUI: a graphical user interface for linear modeling of microarray data JO - Bioinformatics VL - 20 UR - https://doi.org/10.1093/bioinformatics/bth449 DO - 10.1093/bioinformatics/bth449 ID - Wettenhall2004 ER - TY - JOUR AU - Wainberg, M. AU - Alipanahi, B. AU - Frey, B. J. PY - 2016 DA - 2016// TI - Are random forests truly the best classifiers? JO - J Mach Learn Res VL - 17 ID - Wainberg2016 ER - TY - JOUR AU - Lin, L. I. PY - 1989 DA - 1989// TI - A concordance correlation coefficient to evaluate reproducibility JO - Biometrics VL - 45 UR - https://doi.org/10.2307/2532051 DO - 10.2307/2532051 ID - Lin1989 ER - TY - JOUR AU - Kuleshov, M. V. PY - 2016 DA - 2016// TI - Enrichr: a comprehensive gene set enrichment analysis web server 2016 update JO - Nucleic Acids Res VL - 44 UR - https://doi.org/10.1093/nar/gkw377 DO - 10.1093/nar/gkw377 ID - Kuleshov2016 ER -